Search hospitals
>
Ohio
>
Cleveland
Cleveland Clinic Taussig Cancer Center
Claim this profile
Cleveland, Ohio 44106
Global Leader in Brain Tumor
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Cancer
Conducts research for Breast Cancer
769 reported clinical trials
45 medical researchers
Summary
Cleveland Clinic Taussig Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Brain Tumor, Lymphoma, Leukemia, Cancer, Breast Cancer and other specialties. Cleveland Clinic Taussig Cancer Center is involved with conducting 769 clinical trials across 479 conditions. There are 45 research doctors associated with this hospital, such as David Peereboom, MD, Dale Shepard, Aaron Gerds, MD, MS, and Brian Gastman, MD.
Area of expertise
Brain Tumor
Cleveland Clinic Taussig Cancer Center has run 93 trials for Brain Tumor. Some of their research focus areas include:
Lymphoma
Cleveland Clinic Taussig Cancer Center has run 70 trials for Lymphoma. Some of their research focus areas include:
Top PIs
David Peereboom, MD
Cleveland Clinic
6 years of reported clinical research
Dale Shepard
Cleveland Clinic
9 years of reported clinical research
Aaron Gerds, MD, MS
Cleveland Clinic Foundation
6 years of reported clinical research
Brian Gastman, MD
Cleveland Clinic
4 years of reported clinical research
Clinical Trials running at Cleveland Clinic Taussig Cancer Center
Cancer
Acute Myeloid Leukemia
Brain Tumor
Glioblastoma
Colorectal Cancer
Lung Cancer
Bladder Cancer
Ovarian Cancer
Solid Tumors
Breast Cancer
Ivosidenib + Venetoclax +/- Azacitidine
for Leukemia
This phase Ib/II trial studies the side effects and best dose of venetoclax and how well it works when given together with ivosidenib with or without azacitidine, in treating patients with IDH1-mutated hematologic malignancies. Venetoclax and ivosidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ivosidenib and venetoclax with azacitidine may work better in treating patients with hematologic malignancies compared to ivosidenib and venetoclax alone.
Recruiting
3 awards
Phase 1 & 2
Disulfiram + Copper Gluconate + Liposomal Doxorubicin
for Sarcoma
This trial tests a new treatment combining a drug for alcoholism, a copper supplement, and a special chemotherapy for patients whose sarcomas came back or didn't respond to initial treatment. The goal is to make the chemotherapy work better by stopping the cancer from resisting it. Researchers are checking if this combination is safe and effective.
Recruiting
3 awards
Phase 1
18F-Clofarabine PET Imaging
for Cancer
The purpose of this study is to evaluate whether a new type of imaging study, called 18F-Clofarabine (CFA) PET/CT, can be used to image cancer pyrimidine metabolism in participants. PET (positron emission tomography) imaging is a way of looking at cancers that can reveal cancer metabolism. Presently, however, there are no imaging agents in routine use to look at an aspect of cancer metabolism (pyrimidine metabolism) that dictates whether certain cancer drugs, e.g., gemcitabine, are likely to be taken into the cancer cells. This clinical trial will be testing whether 18F-Clofarabine (CFA) could be an imaging agent to measure this aspect of cancer metabolism.
Recruiting
1 award
Phase < 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cleveland Clinic Taussig Cancer Center?
Cleveland Clinic Taussig Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Brain Tumor, Lymphoma, Leukemia, Cancer, Breast Cancer and other specialties. Cleveland Clinic Taussig Cancer Center is involved with conducting 769 clinical trials across 479 conditions. There are 45 research doctors associated with this hospital, such as David Peereboom, MD, Dale Shepard, Aaron Gerds, MD, MS, and Brian Gastman, MD.
Where is Cleveland Clinic Taussig Cancer Center located?
To reach Cleveland Clinic Taussig Cancer Center, located at 10201 Carnegie Ave, Cleveland, OH 44106, from the south, take I-77 or I-71 North to downtown Cleveland. Then, take I-90 East to the Chester Ave. exit and turn right. For real-time driving directions based on live traffic updates, consider using Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Cleveland Clinic Taussig Cancer Center, contact the Patient Financial Advocates at 216.442.1600 or toll-free at 855.831.1284. They offer assistance with insurance coverage, cost estimates, and financial assistance programs. Uninsured or self-paying patients are entitled to a good faith estimate for scheduled services.
What insurance does Cleveland Clinic Taussig Cancer Center accept?
The Cleveland Clinic Taussig Cancer Center accepts a wide range of insurance and managed care plans, including but not limited to: - **Major Insurance Plans**: Network Blue, PPC, Traditional, Humana, MultiPlan Network, United Healthcare. - **Direct-to-Employer Plans**: Cigna Medicare HMO, Florida Blue (BlueMedicare, BlueMedicare Choice), Humana Medicare, United Healthcare - Medicare Solutions. - **Commercial Plans**: Aetna Health Inc., AvMed Health Plans, BCBS Truli for Health, Cigna Healthcare of Florida Inc., Florida Blue (Blue Select, Health Options). For specific coverage and plan participation, it's recommended to contact your insurance provider directly. For assistance, call 844.500.9451 to speak with a Patient Financial Advocate (PFA).
What awards or recognition has Cleveland Clinic Taussig Cancer Center received?
Cleveland Clinic's Taussig Cancer Center is internationally recognized for its comprehensive cancer care and research, supported by over 250 healthcare professionals across various disciplines. As part of the NCCN and NCI-designated Case Comprehensive Cancer Center, it provides access to numerous clinical trials and support programs. Since 2017, Cleveland Clinic has invested $12.3 million in internal funding for research Centers of Excellence, including a notable Center of Excellence in Ewing sarcoma, leading to over $71 million in extramural grant funding.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.